欢迎来到天天文库
浏览记录
ID:5346059
大小:260.52 KB
页数:3页
时间:2017-12-08
《糖脉康颗粒治疗糖尿病周围神经病变临床研究》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、·中西医结合·糖脉康颗粒治疗糖尿病周围神经病变临床研究郭莲,刘维娟【摘要】目的观察糖脉康颗粒治疗糖尿病周围神经病变(DPN)的临床疗效。方法将82例DPN患者随机分为对照组(40例)和治疗组(42例)。两组均给予糖尿病常规治疗,对照组另加用弥可保片,治疗组另加用糖脉康颗粒,两组疗程均为12周。观察治疗前后两组患者的肌电图及同型半胱氨酸(Hey)、糖化血红蛋白(HbA,)、脂质代谢的变化。结果治疗后治疗组患者的疗效显著优于对照组,有效率亦显著高于对照组,差异有统计学意义(P2、传导速度及Hcy水平间差异无统计学意义(P>0.05);但治疗组治疗后HbA三酰甘油(TC)、低密度脂蛋白胆固醇(LDL—C)水平较对照组显著下降,高密度脂蛋白胆固醇(HDL—c)水平较对照组显著升高,差异均有统计学意义(P<0.05)。治疗中,对照组有1例出现皮疹,2例出现胃肠道不适,而治疗组未见明显不良反应。结论糖脉康颗粒治疗DPN疗效优于甲钴胺,还可降低血脂和HbA水平,且不良反应少。【关键词】糖尿病神经病变;糖脉康;甲钴胺;治疗结果’【中图分类号】R587.25【文献标识码】B【文章编号】1007—9572(2010)03、9—2996—03ClinicalObservationonTreatmentofDiabeticPeripheralNeuropathybyTangmaikangGUOLian,LIUWei一0.De-partmentofEndocrinology,ChongqingThreeGorgesCentralHospital,Chongqing404000,China【Abstract】ObjectiveToinvestigatethetherapeuticeffectofTangmaikangondiabeticperiphera4、lneuropathy(DPN).Methods82patientswithDPNwererandomlydividedintotwogroups.Thecontrolgroup(40cases)wastreatedwithconven—tionaltherapyandMethycobaltablets,andthetreatmentgroup(42cases)wastreatedwithTangmaikanginadditiontoconven-tionaltherapyfor12weeks.Observethechanges5、ofelectromyogram,hom0cysteinemia,glycosylatedhemoglobin,lipidmetabo-lismbeforeandaftertreatment.ResultsEficacyoftreatmentgroupismuchbetterthanthatofcontrolgroup,aswellastheef-fectiverate(P<0.05).Thecurativeeffectofmotornerveconductionvelocity、suralnerveconductionvelo6、cityandhomocysteicacidhavenosignificantdifference(P>0.05)aftertreatmentintwogroups.Comparedwithcontrolgroup,theglycosylatedhe—moglobin,TCandLDL—Calldecreasedobviously(P<0.05),HDL—Cincreasedobviously(P<0.05)aftertreatmentintreatmentgroup.Inaddition,breakoutandgastroin7、testinaltractadverseefectwasfoundincontrolgroup,butnotintreatmentgroup.ConclusionTangmaikangissuperiortomecobalaminintreatingDPN,anditcanalsoreducebloodfatlevelandHbAllevel,withfewadverseefects.【Keywords】Diabeticneuropathies;Tangmaikang;Methycobal;Treatmentoutcome糖尿病8、周围神经病变(DPN)是一醇途径、非酶性糖化、氧化应激、神经血病患者82例:(1)均按照1999年WHO种与糖尿病(DM)症状有关的神经病流降低、血液流变学异常等,但目前糖尿病诊断标准确诊为2型糖尿病;(2)变,与高血糖持续时间及严重程度均明确已有的主流治疗药物
2、传导速度及Hcy水平间差异无统计学意义(P>0.05);但治疗组治疗后HbA三酰甘油(TC)、低密度脂蛋白胆固醇(LDL—C)水平较对照组显著下降,高密度脂蛋白胆固醇(HDL—c)水平较对照组显著升高,差异均有统计学意义(P<0.05)。治疗中,对照组有1例出现皮疹,2例出现胃肠道不适,而治疗组未见明显不良反应。结论糖脉康颗粒治疗DPN疗效优于甲钴胺,还可降低血脂和HbA水平,且不良反应少。【关键词】糖尿病神经病变;糖脉康;甲钴胺;治疗结果’【中图分类号】R587.25【文献标识码】B【文章编号】1007—9572(2010)0
3、9—2996—03ClinicalObservationonTreatmentofDiabeticPeripheralNeuropathybyTangmaikangGUOLian,LIUWei一0.De-partmentofEndocrinology,ChongqingThreeGorgesCentralHospital,Chongqing404000,China【Abstract】ObjectiveToinvestigatethetherapeuticeffectofTangmaikangondiabeticperiphera
4、lneuropathy(DPN).Methods82patientswithDPNwererandomlydividedintotwogroups.Thecontrolgroup(40cases)wastreatedwithconven—tionaltherapyandMethycobaltablets,andthetreatmentgroup(42cases)wastreatedwithTangmaikanginadditiontoconven-tionaltherapyfor12weeks.Observethechanges
5、ofelectromyogram,hom0cysteinemia,glycosylatedhemoglobin,lipidmetabo-lismbeforeandaftertreatment.ResultsEficacyoftreatmentgroupismuchbetterthanthatofcontrolgroup,aswellastheef-fectiverate(P<0.05).Thecurativeeffectofmotornerveconductionvelocity、suralnerveconductionvelo
6、cityandhomocysteicacidhavenosignificantdifference(P>0.05)aftertreatmentintwogroups.Comparedwithcontrolgroup,theglycosylatedhe—moglobin,TCandLDL—Calldecreasedobviously(P<0.05),HDL—Cincreasedobviously(P<0.05)aftertreatmentintreatmentgroup.Inaddition,breakoutandgastroin
7、testinaltractadverseefectwasfoundincontrolgroup,butnotintreatmentgroup.ConclusionTangmaikangissuperiortomecobalaminintreatingDPN,anditcanalsoreducebloodfatlevelandHbAllevel,withfewadverseefects.【Keywords】Diabeticneuropathies;Tangmaikang;Methycobal;Treatmentoutcome糖尿病
8、周围神经病变(DPN)是一醇途径、非酶性糖化、氧化应激、神经血病患者82例:(1)均按照1999年WHO种与糖尿病(DM)症状有关的神经病流降低、血液流变学异常等,但目前糖尿病诊断标准确诊为2型糖尿病;(2)变,与高血糖持续时间及严重程度均明确已有的主流治疗药物
此文档下载收益归作者所有